Trevena to Present at the 2017 Barclays Global Healthcare Conference
March 10 2017 - 7:00AM
Trevena, Inc. (NASDAQ:TRVN) today announced that it will be
presenting at the 2017 Barclays Global Healthcare Conference on
Tuesday, March 14, 2017 at 11:15 a.m. EDT in Miami.
To join a live audio webcast of the presentation, please visit
the Investor section of the Company’s website. Following the
conclusion of the presentation, the webcast will be available for
replay for 30 days.
About Trevena
Trevena, Inc. is a biopharmaceutical company developing
innovative therapies based on breakthrough science to benefit
patients and healthcare providers confronting serious medical
conditions. The Company has discovered four novel and
differentiated drug candidates, including OLINVO™ (oliceridine
injection). Trevena also has discovered TRV250, in preclinical
development for the treatment of migraine, and TRV734, for pain.
The Company is actively working on an early stage portfolio of drug
discovery programs.
Contacts
Trevena, Inc.
Investors:
Jonathan Violin, Ph.D.
Sr. Director, Investor Relations
610-354-8840 x231
jviolin@trevena.com
or
Media:
Public Relations
PR@trevena.com
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Apr 2023 to Apr 2024